As the biopharmaceutical industry explores innovative and novel ways to handle the complexities of drug formulation, artificial intelligence (AI) technology is experiencing a marked rise in incorporation. Processor-intensive tasks such as antibody engineering, which were once hindered by time and resource constraints, are now becoming quicker and more efficient thanks to AI.
...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian